Deferred Tax Assets, Valuation Allowance of KALA BIO, Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
KALA BIO, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • KALA BIO, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $139,507,000, a 8.4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

KALA BIO, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $139,507,000 +$10,776,000 +8.4% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $128,731,000 +$7,325,000 +6% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $121,406,000 -$2,727,000 -2.2% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $124,133,000 +$36,568,000 +42% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q4 2020 $87,565,000 +$17,492,000 +25% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 $70,073,000 +$13,490,000 +24% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $56,583,000 +$16,409,000 +41% 31 Dec 2018 10-K 12 Feb 2020 2019 FY
Q4 2017 $40,174,000 -$861,000 -2.1% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 $41,035,000 31 Dec 2016 10-K 02 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.